Qualifying Notice for Gavreto (French, HTML)

Qualifying Notice for Gavreto: French HTML file. From Health Canada, updated Nov 2023. View metadata, licence and the direct download on CanQuery.

Format
HTML
Access
Original download only
Publisher-reported update
2023-11-01

This Notice of Compliance with Conditions Qualifying Notice (NOC/c-QN), issued in accordance with the Health Canada Guidance Document: Notice of Compliance with Conditions (NOC/c), is to advise you that information submitted in support of the New Drug Submission for Gavreto (pralsetinib), Control Number 243731, for the indication of the treatment of adult patients with rearranged during transfection (RET) fusion-positive locally advanced unresectable or metastatic non-small cell lung cancer (NSCLC).

Access original file

Data overview

Formats
HTML
File languages
French
Available actions
Access original file

Official sources and licences

Related open data